Investigation of post-treatment after immune checkpoint inhibitor treatment for advanced or recurrent non-small cell lung cancer
Not Applicable
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000033594
- Lead Sponsor
- Japanese Red Cross Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
Not provided
Exclusion Criteria
Patient, or family refuses to participate in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Progression-free survival Overall survival Side effect Types of immunity checkpoint inhibitors Types of anti-cancer drugs